Myocarditis

C Basso - New England Journal of Medicine, 2022 - Mass Medical Soc
Myocarditis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …

[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

C Tschöpe, E Ammirati, B Bozkurt… - Nature Reviews …, 2021 - nature.com
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …

COVID-19 and cardiovascular disease: from bench to bedside

MK Chung, DA Zidar, MR Bristow, SJ Cameron… - Circulation …, 2021 - Am Heart Assoc
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …

Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document

E Ammirati, M Frigerio, ED Adler, C Basso… - Circulation: Heart …, 2020 - Am Heart Assoc
Myocarditis is an inflammatory disease of the heart that may occur because of infections,
immune system activation, or exposure to drugs. The diagnosis of myocarditis has changed …

Diagnosis and treatment of acute myocarditis: a review

E Ammirati, JJ Moslehi - Jama, 2023 - jamanetwork.com
Importance Acute myocarditis, defined as a sudden inflammatory injury to the myocardium,
affects approximately 4 to 14 people per 100 000 each year globally and is associated with …

[HTML][HTML] Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection

S Rajpal, MS Tong, J Borchers, KM Zareba… - JAMA …, 2021 - jamanetwork.com
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From
COVID-19 Infection | Cardiology | JAMA Cardiology | JAMA Network [Skip to Navigation] Our …

Myocarditis in patients treated with immune checkpoint inhibitors

SS Mahmood, MG Fradley, JV Cohen, A Nohria… - Journal of the American …, 2018 - jacc.org
Background: Myocarditis is an uncommon, but potentially fatal, toxicity of immune checkpoint
inhibitors (ICI). Myocarditis after ICI has not been well characterized. Objectives: The authors …

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

L Zhang, M Awadalla, SS Mahmood… - European heart …, 2020 - academic.oup.com
Aims Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI).
Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated …

Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement

D Phelan, JH Kim, MD Elliott, MM Wasfy, P Cremer… - Cardiovascular …, 2020 - jacc.org
As our understanding of the complications of coronavirus disease-2019 (COVID-19) evolve,
subclinical cardiac pathology such as myocarditis, pericarditis, and right ventricular …

Myocardial T1 and T2 mapping by magnetic resonance in patients with immune checkpoint inhibitor–associated myocarditis

P Thavendiranathan, L Zhang, A Zafar… - Journal of the American …, 2021 - jacc.org
Background Myocarditis is a potentially fatal complication of immune checkpoint inhibitor
(ICI) therapy. Data on the utility of cardiovascular magnetic resonance (CMR) T1 and T2 …